Omigen, Inc. is a startup company founded by Formal UCLA professor, Dr. Yunguang Tong. Omigen, Inc. is specialized in providing NGS-based genomic solutions to the industry with a focus on clinical diagnostics and assay development. It recently developed ctDNA detection technology is the leading technology in the field. The company is headquartered in Hangzhou, China, there are subsidiaries and laboratories in Los Angeles, USA.